Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns

• Ngā kaituhi matua: Ainhoa Gochi Valdovinos (Author), María Arriaga-Redondo (Author), Ester Dejuan Bitriá (Author), Isabel Pérez Rodríguez (Author), Elena Márquez Isidro (Author), Dorotea Blanco Bravo (Author)
• Hōputu: Pukapuka
• I whakaputaina: Elsevier, 2022-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Introduction: Magnesium sulphate (MgSO4) therapy has shown to be useful as a neurological protector in the preterm newborn below 32 weeks of gestation. The most documented adverse effect is cardiorespiratory failure, whereas its relationship with meconium obstruction is controversial. The main objec...